Filing Flows › GoodRx Holdings (GDRX) › Q4 2025
GoodRx Holdings (GDRX) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 26, 2026
GoodRx Holdings (GDRX) reported revenue of $195M for the fourth quarter 2025 (Q4 2025), -2% from a year earlier and -0.6% from the quarter before. Operating margin was 11.6%, net earnings $5.4M (2.8% of revenue).
GoodRx Holdings, Q4 2025: revenue $195M (-2% year over year), operating margin 11.6%, net earnings $5.4M, operating cash flow $32.9M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $195M | -0.6% | -2% |
| Operating profit | $22.7M | +55% | +25% |
| Net earnings | $5.4M | +385% | -20% |
| Operating cash flow | $32.9M | -57% | -26% |
| Free cash flow | $31.6M | -57% | -29% |
What changed
Revenue was $194.8M in Q4 2025, down 2% year over year and down 1% from the previous quarter.
Operating profit was $22.7M, a 11.6% margin (up 2.5 points year over year). Total costs fell 5% while revenue fell 2%. The fastest-growing cost line was Cost of revenue (+43%). Net earnings were $5.4M, down 20% year over year. The effective tax rate was 61.8%.
Operating cash flow was $32.9M (down 26% year over year), 606% of net earnings. Non-cash charges added back $23.1M of depreciation and amortization and $17.9M of share-based compensation. Working capital and other items used $13.6M. Capital expenditures of $1.2M left free cash flow of $31.6M.
Questions
What was GoodRx Holdings' revenue in the fourth quarter 2025?
GoodRx Holdings (GDRX) reported revenue of $195M for the fourth quarter 2025 (Q4 2025), -2% from a year earlier and -0.6% from the quarter before.
Was GoodRx Holdings profitable in the fourth quarter 2025?
Operating profit was $22.7M (11.6% of revenue) and net earnings $5.4M.
Source: GoodRx Holdings 10-K on SEC EDGAR.